Blood Weekly articles from September 2002

Blood Weekly archives from September 2002

New screening test may help predict relapse.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- A new screening test to be piloted in Bristol could help to revolutionize the way children with leukemia are treated by enabling doctors to fine-tune treatment to the needs of each individual patient....

Cyclosporine adds little benefit to prednisone treatment for graft-versus-host disease.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Prednisone monotherapy may be the best choice for patients who develop graft-versus-host disease after stem cell transplantation, researchers say. "Results...

Molecular diagnostics and the future of healthcare discussed at AACC meeting.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- At a news conference by Roche Diagnostics at the American Association for Clinical Chemistry (AACC), special guest speaker Dr. Ellen Jo Baron of Stanford University discussed developing and future...

Cycling fetal progenitors capable of efficient engraftment.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Unlike their adult counterparts, fetal hematopoietic stem cells retain their engraftment potential during active phases of the cell cycle, researchers say. ...

Bone marrow cell transplantation could save limbs.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Injecting a patient's bone marrow cells into their legs could help repair damaged circulatory systems in those with limb ischemia, suggest authors of a trial in the August 10, 2002, Lancet. Lower...

Serologicals Corp. names James J. Kramer, PhD, VP, plasma operations.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Serologicals Corp. (SERO) announced that James J. Kramer, PhD, has been named vice president, plasma operations. Kramer will report directly to David A. Dodd, president and CEO, and will serve as a...

U.S. military orders 15 Piccolo Blood Chemistry Analyzers.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc., (ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced it had received an order from the U.S. military for 15 of its Piccolo Blood Chemistry...

Micrologix Signs license agreement with Fujisawa.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Micrologix Biotech, Inc., a biotechnology company focused on anti-infective drug development, and Fujisawa Healthcare, Inc., the U.S. subsidiary of Fujisawa Pharmaceutical Co., Ltd., a global developer...

New study said to find more evidence BSE can be transmitted via blood.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- The British government said August 3, 2002, it was considering banning recipients of transfusions from donating blood, after a newspaper reported that new research provides further evidence mad cow...

ThermoGenesis to expand CryoSeal FS pivotal trial.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- ThermoGenesis Corp. (KOOL) announced that an independent data safety monitoring board (DSMB) comprised of surgeons, a biostatistician and an ethicist recommends proceeding with the multicenter pivotal...

3-for-2 stock split announced.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Immucor, Inc., (BLUD), the global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced that its board of directors has approved a 3-for-2 stock split,...

TKT announces victory in Dynepo U.K. patent litigation.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Transkaryotic Therapies, Inc., (TKTX) announced that the Court of Appeal in the United Kingdom has issued a unanimous opinion in favor of TKT and Aventis Pharma in a patent infringement suit involving...

HyperBaric Systems receives first patent.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- HyperBaric Systems (HYRB) announced that the company has received its first patent on technology and methodology for preserving blood platelets. The patent document, numbered U.S. 6,413,713, B1, was...

Lentiviral vectors improve transduction efficiency in liver and blood cells.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writers - Medical investigators have proposed that modified lentiviral vectors would be useful as genetic vaccines and for treating genetic blood disorders, liver...

Northfield Laboratories urges caution regarding dissident shareholder.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Northfield Laboratories, Inc., (NFLD), developer of an oxygen-carrying blood substitute for trauma and elective surgery situations, urged its shareholders not to sign any proxy card sent to them by...

Transforming growth factor beta1 upregulates CD34.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Italy have elucidated the effects of transforming growth factor beta1 (TGF-beta1) on hematopoietic stem cells. "Stem/progenitor cells...

Preradiotherapy growth factor treatment can improve engraftment.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hematopoietic growth factor treatment could improve the outcome of autologous stem cell transplantation, researchers in the Netherlands report. ...

Methodist Hospital opens Bloodless Medicine Center.
September 5, 2002... 2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Methodist Hospital of Southern California has implemented a new program to conserve blood and avoid the use of transfusions whenever possible. "In essence, we have created a center for blood...

Novel nucleic acid tests suitable for large-scale HIV, hepatitis C blood donor screening.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have developed a highly sensitive assay system for finding HIV or hepatitis C infection in blood. "Various nucleic acid...

Cord blood cells can be used to create new heart vessels.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Stem cells from human umbilical cord blood can be a useful tool for arterial remodeling and reconstruction, researchers report. "Tissue engineering...

Intrinsic coagulation pathway helps mediate plaque-induced thrombosis.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and Japan have presented evidence challenging widely held assumptions about the hemostatic effects of arterial plaque. ...

Latin Americans and Caribbeans know little about blood donation, study shows.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- Many people in Latin America and the Caribbean know little about blood donation and have difficulty accessing blood services, according to a study in 15 countries sponsored by the Pan American Health...

Removing first-collected blood lowers contamination risk.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the Netherlands say that removing the first few milliliters of donated blood from blood products can reduce their recipients' infection risk....

i-STAT appoints executive vice president of commercial operations.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- i-STAT Corp. (STAT) announced the appointment of Bruce F. Basarab as executive vice president of commercial operations, a new position for the company. "Bruce brings proven leadership skills gained...

Second quarter net loss: $0.20 per share.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- Corvas International, Inc., (CVAS) reported financial results for the second quarter of 2002, which were in line with management's expectations. Second quarter operating revenues of $46,000 and...

Second quarter pro forma results: $0.29 per share.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) reported pro forma net income from continuing operations of $56 million or $0.29 per share for the second quarter of 2002, compared with $40 million, or $0.21 per share, in...

Patients with bleeding disorder face liver disease from bloodborne pathogens.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The cumulative incidence of hepatitis C virus (HCV)-related end-stage liver disease in patients with hemophilia increases with human immunodeficiency virus...

Northfield Laboratories announces board and management changes.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- Northfield Laboratories, Inc., (NFLD), a developer of an oxygen-carrying blood substitute for trauma and elective surgery situations, announced that Richard E. DeWoskin, one of the company's founders...

In utero stem cell transplants show promise.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Stem cell grafts may be a valuable in utero treatment for children who will be born with muscular dystrophy, researchers in the United States report. "In...

Adult stem cells selectively delivered into the eye and used to control angiogenesis.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- A team of researchers from the Scripps Research Institute (TSRI) has discovered a way to use adult bone marrow stem cells to form new blood vessels in the eye or to deliver chemicals that will prevent...

All-trans retinoic acid protects stem cells from apoptosis.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in France say that all-trans retinoic acid (ATRA) can protect stem cells from apoptotic processes. "The regulation of apoptosis plays a key...

Filgrastim-stimulated whole blood grafts cheap, safe, effective.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the Netherlands may have found a safe and effective way to lower the cost of hematopoietic stem cell autotransplantation. Andries R....

Company's revenues decrease 3%.
September 12, 2002... 2002 SEP 12 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc., (ABAX), a medical products company manufacturing point-of-care blood analysis systems, reported financial results for its first fiscal quarter ended June 30, 2002. For the quarter,...

Skin antisepsis kits reduce blood sample contamination.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Two commonly used antiseptic skin wipes are equally effective for preserving blood sample integrity, researchers found. "Skin preparation is an important...

Recombinant G-CSF aids post-transplant recovery.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Turkey say that a recombinant hematopoietic growth factor can help patients recovering from stem cell transplantation. Taner Demirer and...

Preemptive lamivudine inhibits hepatitis B effects after transplantation.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Lamivudine can be used to curb hepatitis B virus (HBV) exacerbation in people who receive hematopoietic cell transplantations, scientists report. The...

Plasminogen activator inhibitor-1 marks post-transplant, veno-occlusive disease.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in South Korea have identified several markers for a dangerous liver condition in bone marrow transplantation (BMT) patients. Je-Hwan Lee and...

Self-donation of blood before surgery may not always benefit hip replacement patients.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Preoperative autologous blood donation for patients undergoing total hip replacement may not be necessary and, in some cases, may increase the likelihood of unnecessary autologous transfusion, waste of...

Drug reduces transfusions and chemotherapy-related fatigue.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Patients treated with darbepoetin alfa (Aranesp) for chemotherapy-induced anemia may require fewer blood transfusions and feel less fatigued than patients receiving a placebo, concludes a new study in...

Hemopure marketing application submitted to FDA.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Biopure Corporation (BPUR) announced that it has submitted an electronic Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its oxygen therapeutic Hemopure...

U.K. National Blood Service making further improvements to blood safety.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- U.K. Public Health Minister Hazel Blears announced that the National Blood Service is making further improvements to blood safety. Fresh frozen plasma for newborn babies and young children born...

Laser-based malaria test could be valuable.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel assay can find low levels of malaria-causing parasites in blood, researchers in the United States report. Plamen Demirev and colleagues at Johns...

RenalTech International begins U.S. clinical trial of the BetaSorb device.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- RenalTech International announced that it has initiated a U.S. clinical trial of its BetaSorb device in patients with chronic kidney failure. The trial will evaluate the removal of marker toxins...

All-time monthly sales record posted.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- CRYO-CELL International, Inc., (CCEL) announced that the company reached record monthly sales with unaudited July 2002 revenues of approximately $638,000. Highlights for July 2002 include the...

Bio-Rad Reports Second Quarter Results.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO; BIO.B) announced second quarter financial results for the quarter and 6-month period ended June 30, 2002. For the quarter, revenues were $214.7 million, an...

Additive that makes juices tart, quadruples yield of essential treatment.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- The common additive that gives tartness to orange juice, lemon juice and sodas also can dramatically boost the production of a protein critical for treating victims of hemophilia and other bleeding...

Hepatitis worse during immunocompetence with HIV/hepatitis C coinfection.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Ironically, liver disease may worsen when there is immunocompetence in hemophiliacs coinfected with human immunodeficiency virus (HIV) and hepatitis C virus...

Virax to develop hepatitis B treatment with New York Blood Center.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Virax Holdings, Ltd., has signed a development agreement with the New York Blood Center to develop a treatment for hepatitis B (HBV) infection. The new treatment is Virax's third product under...

Roche Molecular initiates trials of Cobas AmpliScreen HBV test.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Roche Molecular Systems, Inc., (Roche) announced the start of comprehensive clinical trials of its Cobas AmpliScreen HBV test. The trials mark an important milestone because, for the first time in...

West Nile virus risk level rises.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- The Metropolitan Washington Council of Governments (COG) announced that with the first confirmed human case of West Nile virus, the metropolitan Washington region now is at Risk level 4 as outlined in...

Cost-cutting measures can extend benefits to low-resource areas.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Stem cell transplants can be safely and effectively performed at significantly reduced expense to patients, researchers in India find. "Autologous...

Unrelated enriched grafts carry high risk, even with donor lymphocyte infusions.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Enriched stem cell grafts from unrelated donors carry a high morbidity risk, even for patients treated with additional prophylactic procedures, researchers in...

Drug-free organ transplants possible for some patients.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Results of three studies presented at the International Congress of the Transplantation Society provide encouraging evidence that a patient's immune system can be fooled into accepting a transplanted...

Nationwide tissue distribution plan devised.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- As a result of the need for tissue donations for victims of the September 11 terrorist attacks, a nationwide plan has been developed to make tissue available in the event of future disasters. ...

Deviant gene may up risk.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Only about one in five people infected with the West Nile virus develop a severe, life-threatening illness. A study in mice suggests a gene variation may be the reason some become very sick from the...

FDA approves drug trial.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Patients infected with the West Nile virus may be eligible to receive a drug previously used to treat hepatitis C as part of a government-approved national trial to combat the mosquito-borne virus. ...

Mosquitoes pose a threat.
September 19, 2002... 2002 SEP 19 - (NewsRx.com & NewsRx.net) -- As the threat of West Nile Virus spreads to several areas of the country, including recent cases in Louisiana, the skin/itch experts at the Lanacane Itch Information Center offer some tips to help keep...

Molecular C. albicans blood test fast, effective.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel molecular assay can quickly and accurately confirm the presence of Candida albicans in blood cultures, researchers say. Susan Rigby and colleagues...

Prostaglandin mediates donor-specific transfusion benefits in heart transplant patients.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan have shed new light on the effects of donor-specific blood transfusion (DST) for patients undergoing heart or other organ transplantion....

NycoPrep can be used for density gradient cell separation.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The nonionic x-ray contrast agent iohexol (NycoPrep) can be used to separate mononuclear cell subsets in donated blood, researchers in Norway report. ...

NEJM address role of BNP blood test.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Studies published in the New England Journal of Medicine and in Circulation: Journal of the American Heart Association support the value of B-type natriuretic peptide (BNP) in the diagnosis of...

Strict platelet transfusion policy safe, cost-effective for leukemia/lymphoma patients.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A rigidly conservative prophylactic platelet transfusion policy is safe for hematological cancer patients and cost effective for the hospitals that treat them,...

i-STAT to resume direct distribution of its point-of-care products.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- i-STAT Corp. (STAT), a leading manufacturer of point-of-care diagnostic systems for blood analysis, announced that on January 1, 2004, following the conclusion of its current marketing and distribution...

Researchers hope to use cow clones as medicine factories.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Four cloned calves genetically engineered with human DNA and currently grazing in Iowa could hold the key to creating herds of identical cows that produce medicines in their milk and blood. "Cows...

Mochida receives import approval for Osteomark NTx Serum test.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Ostex International, Inc., (OSTX) announced its Japanese partner, Mochida Pharmaceutical Co., Ltd., has been granted import approval for the Osteomark NTx Serum test in Japan. Ostex will now begin...

British stem cell bank could be open within a year.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Europe's first stem cell bank could be open and ready to receive cells within a year, the head of the group newly chosen to run it said September 9, 2002. Britain's Medical Research Council...

ThermoGenesis, Minogue ink Canadian distribution agreement for CryoSeal FS.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- ThermoGenesis Corp. (KOOL) announced that it has signed a distribution agreement with Minogue Medical, a surgical specialty distributor with offices in Montreal and direct multilingual sales people...

Maker of antibody-based products reports 37% increase in sales.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Serologicals Corp. (SERO) reported results for the second quarter and 6 months ended June 30, 2002. Net revenues for the second quarter of 2002 totaled $37.3 million as compared with $27.2 million...

Rockwell reports 17.9% increase in second quarter sales.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Rockwell Medical Technologies, Inc., (RMTI), a hemodialysis concentrate manufacturer in the healthcare industry, reported that second quarter 2002 revenue was $2,562,594, an increase of 17.9% over the...

Controversial rapid screen effective after occupational exposure.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A controversial rapid HIV test can be effectively used to screen for infection after occupational exposure, researchers in Virginia argue. "The Single Use...

Improved HIV viral load test approved by FDA.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Roche Diagnostics announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for the Roche Amplicor HIV-1 Monitor Test, version 1.5. This test is a highly...

Rockwell Medical Technologies, National Nephrology Associates, ink contract.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Rockwell Medical Technologies, Inc., (RMTI), a hemodialysis concentrate manufacturer, announced that it has signed a supply contract with National Nephrology Associates, Inc., (NNA). NNA owns and...

CIRAD, Institut Pasteur and IRD partners in research on emerging vector-borne diseases.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- On July 8, 2002 the Centre for International Cooperation in Agronomic Research for Development (CIRAD), the Institut Pasteur and the Institut de Recherche pour le Developpement (IRD) signed a framework...

Immune system supressor drug found effective in treating precancerous blood disorder.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- A medicine typically used in organ transplant patients shows promise in treating older patients who have a precancerous blood disorder for which there is currently no effective treatment besides blood...

Delayed resection reduces blood loss after tumor embolization.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Delayed removal of embolized brain tumors is associated with lower surgical blood loss, researchers say. "Embolization before surgical resection of tumors...

Sangamo gets federal grant to apply ZFP technology.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Sangamo BioSciences, Inc., (SGMO) announced that the company has been awarded a $1 million NIH grant to conduct research on the application of Sangamo's zinc finger DNA binding transcription factor...

Serologicals Corp. announces multiyear agreement for vaccinia plasma.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Serologicals Corp. (SERO) has entered into a multiyear agreement with Cangene Corp. to provide hyperimmune plasma for use in the manufacturing of vaccinia immune globulin (VIg), to be used in treating...

Thrombopoietin enhances other growth factors' effects on premature cord blood.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The platelet growth factor thrombopoietin (TPO) enhances the effects of other cytokines on preterm cord blood, researchers say. Der-Cherng Liang and...

Total parenteral nutrition increases morbidity risk.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Total parenteral nutrition should be not be routinely administered to stem cell transplant recipients, researchers in Turkey warn. "One of the major...

Epoetin alfa can lower transfusion needs during head and neck cancer surgery.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Epoetin alfa can reduce the need for blood transfusions during and after surgery to treat head and neck cancer, researchers say. Shaun N. Scott and...

New drugs, novel use of therapies, enhance transplant success.
September 26, 2002... 2002 SEP 26 - (NewsRx.com & NewsRx.net) -- New side-effect sparing drugs and prophylactic uses of acute immunosuppressive therapies such as novel antimetabolites, monoclonal, and polyclonal antibodies are furthering the success of transplants...